SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-21-022109
Filing Date
2021-09-14
Accepted
2021-09-14 16:12:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A atos20210913_defa14a.htm DEFA14A 32089
2 logo.jpg GRAPHIC 11185
  Complete submission text file 0001437749-21-022109.txt   43236
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35610 | Film No.: 211252530
SIC: 2834 Pharmaceutical Preparations